LLY
Eli Lilly and Company
LLY has the edge over PSNL overall, supported by stronger fundamentals and lower modeled downside.
PSNL
Personalis, Inc.
PSNL's outlook is improving, though it still trails on the overall score.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
PSNL Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
PSNL's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
PSNL PE Valuation
PSNL has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
PSNL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect PSNL's losses to shrink, with revenue growing.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over PSNL on earnings quality, reporting a profit while its opponent remains loss making.
PSNL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.17 | -$0.29 |
| Q2 2026 | -$1.09 | +$0.19 |
| Q1 2026 | -$1.02 | +$0.27 |
| Q4 2025 | -$0.91 | +$0.46 |
| Q3 2025 | -$0.88 | +$0.80 |
| Q2 2025 | -$1.28 | +$0.36 |
| Q1 2025 | -$1.29 | +$0.61 |
| Q4 2024 | -$1.37 | +$0.88 |
PSNL is still losing money, but far less than before: $1.17 per share over the past year, against $2.48 at its worst in late 2022.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over PSNL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over PSNL on profitability, with a higher operating margin.
PSNL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $25.6M | +77% |
| Q2 2026 | $22.4M | +30% |
| Q1 2026 | $15.5M | -25% |
| Q4 2025 | $17.3M | +3.2% |
| Q3 2025 | $14.5M | -44% |
| Q2 2025 | $17.2M | -24% |
| Q1 2025 | $20.6M | +5.5% |
| Q4 2024 | $16.8M | -15% |
PSNL's revenue is growing: $26M last quarter, up 77% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -139% | +22 points |
| Q2 2026 | -150% | -24 points |
| Q1 2026 | -208% | -122 points |
| Q4 2025 | -146% | -38 points |
| Q3 2025 | -161% | -105 points |
| Q2 2025 | -127% | -52 points |
| Q1 2025 | -86% | +11 points |
| Q4 2024 | -108% | +14 points |
PSNL's operating margin was −139% last quarter, up 22 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over PSNL on cash generation, producing positive trailing cash flow while its opponent burns cash.
PSNL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$30.1M | -$6.7M |
| Q2 2026 | -$29.6M | -$16.3M |
| Q1 2026 | -$25.7M | -$5.2M |
| Q4 2025 | -$22.3M | -$13.3M |
| Q3 2025 | -$23.4M | -$17M |
| Q2 2025 | -$13.2M | -$2.5M |
| Q1 2025 | -$20.5M | +$45K |
| Q4 2024 | -$9M | +$7.9M |
PSNL has burned cash in almost every quarter: −$108M over the past year, against −$66M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over PSNL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
PSNL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.7% | +1.8M shares |
| 1 year | +21% | +18.5M shares |
| 3 years | +125% | +59.5M shares |
| 5 years | +144% | +63.2M shares |
| Available history | +242% | +75.9M shares |
PSNL has 107M diluted shares, up 21% from a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
PSNL Net Leverage
PSNL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
PSNL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 50.9 | Neutral |
PSNL's weekly RSI is 60 (neutral) and its Stochastic is 51 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
PSNL PE vs Healthcare Sector
PSNL has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over PSNL on trend strength, trading above more of its moving averages.
PSNL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.0 | 0.6% below |
| 20 week MA | $15.4 | 2.8% above |
| 50 week MA | $11.2 | 42% above |
| 100 week MA | $8.46 | 87% above |
| 200 week MA | $5.45 | 191% above |
PSNL's trend is up, with a small recent dip: it's below only its 8-week average, and 191% above its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.
PSNL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.68 | $41.5 | +329% |
| 2021 | $41.5 | $14.4 | -65% |
| 2022 | $14.4 | $1.95 | -86% |
| 2023 | $1.95 | $2.10 | +7.7% |
| 2024 | $2.10 | $5.87 | +180% |
| 2025 | $5.87 | $8.14 | +39% |
| 2026 YTD | $8.14 | $15.9 | +95% |
PSNL has the edge over LLY on returns for 2026, with the stronger performance.